Vanda Pharmaceuticals
VNDA
#8812
Rank
S$0.26 B
Marketcap
S$4.44
Share price
-6.13%
Change (1 day)
-33.87%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2026 (TTM): S-$5.94

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S-$5.96. In 2025 the company made an earnings per share (EPS) of S-$4.81 a decrease over its 2024 EPS that were of S-$0.41.

EPS history for Vanda Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$5.9423.46%
2025S-$4.811065.63%
2024S-$0.41-710.9%
2023S$0.06757-56.35%
2022S$0.15-80%
2021S$0.77
2019S$2.80334%
2018S$0.64-247.06%
2017S-$0.44-19.05%
2016S-$0.54-55.32%
2015S-$1.21-347.37%
2014S$0.49-156.72%
2013S-$0.86-31.63%
2012S-$1.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-244.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.77-213.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.92-115.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.85-768.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.28-121.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.83-197.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
S-$5.66-4.98%๐Ÿ‡บ๐Ÿ‡ธ USA